5 Best Income Stocks to Buy According to Analysts

4. Pfizer Inc. (NYSE:PFE)

Upside Potential as of May 1: 22.5%
Average Price Target Based on Analyst Ratings: $47.6

Pfizer Inc. (NYSE:PFE) is next on our list of the best dividend stocks. On April 26, the company declared a quarterly dividend of $0.41 per share, which was in line with its previous dividend. It has been raising its dividends consistently for the past 13 years. The stock’s dividend yield on May 1 came in at 4.22%.

BofA maintained a Neutral rating on Pfizer Inc. (NYSE:PFE) in April with a $45 price target, giving a positive outlook on the company’s upcoming quarters.

At the end of December 2022, 75 hedge funds tracked by Insider Monkey owned investments in Pfizer Inc. (NYSE:PFE), with a collective value of over $2.5 billion.

Diamond Hill Capital mentioned Pfizer Inc. (NYSE:PFE) in its Q3 2022 investor letter. Here is what the firm has to say:

“Also among our bottom contributors were health care products manufacturer Abbott Labs, global pharmaceutical company Pfizer Inc. (NYSE:PFE), media and technology giant Alphabet, and insurance company American International Group (AIG). Although Pfizer continues to report strong performance of its core drugs, sales of its COVID vaccine and treatment have likely peaked and sales are expected to decline going forward. We remain optimistic about the company long term as we believe management is taking the company in the right direction, focusing R&D, and making strategic acquisitions with profits generated from COVID vaccine sales.”